Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Sativa Investments refines Orderly Market Agreements to improve liquidity for NEX traded shares

The group, the UK's first medicinal cannabis investment vehicle, said it has made the move because it is “aware of the exceptional and growing demand amongst investors to own shares in the Company”
Cannabis plants
Sativa said its directors remain subject to the Lock-In Agreements entered into on admission, but they will no longer be required to make further shares available

Sativa Investments PLC (NEX: SATI) has moved to improve liquidity in its NEX-listed stock by agreeing to a refinement of the Orderly Market Agreements entered into at the time of its float at the end of March.

The group, the UK's first medicinal cannabis investment vehicle, said it has made the move because it is “aware of the exceptional and growing demand amongst investors to own shares in the Company.”

READ: Sativa Investments buys UK medicinal cannabis lab for £435K

All investors who subscribed for Sativa’s ordinary shares in the company at admission entered into an Orderly Market Agreement and the group’s directors of Sativa agreed, should demand arise, to exercise their allocated options and sell the resulting ordinary shares through its corporate adviser and broker, Peterhouse Capital Limited.

However, given the unprecedented demand in the market for its shares, and the desire of Sativa’s directors not to have to be the sole suppliers of stock at levels which its board believes do not reflect the long-term value of the company, it has agreed that all shareholders who are subject to the current Orderly Market Agreements will be permitted to trade in the stock.

The firm added that such trading on the NEX Exchange Growth Market will require the consent of Peterhouse, although it added such consent should not “be unreasonably withheld”.

Sativa said its directors remain subject to the Lock-In Agreements entered into on admission, but they will no longer be required to make further shares available through the exercise of their options.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full SATI profile View Profile

Sativa Investments Timeline

Related Articles

cholesterol on a dial
September 24 2018
"The formation of ProBiotix Health and appointment of Adam Reynolds as chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing,” said chief executive Stephen O’Hara
scientist looking through microscope
April 11 2018
Kumaraguru Raja sees “multiple catalysts” in the year ahead which could put a rocket under the share price
1528305384_Untitled-design-(3).jpg
June 06 2018
Ventripoint received key FDA approval to sell the device with the four-chamber heart analysis last month

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use